New Delhi, September 3rd, 2025: The Association of Indian Medical Device Industry (AiMeD) has welcomed the government’s latest notification amending the Uniform Code for Marketing Practices in Medical Devices (UCMPMD), saying it would bring much-needed transparency, fairness, and accountability to India’s growing MedTech sector.

The Ministry of Chemicals and Fertilizers, through Circular 3/2025, has introduced mandatory annual disclosure norms, simplified reporting formats, and clearer valuation rules for free samples. Chief executives or managing directors of medical device companies will now have to file annual declarations of marketing expenditure within two months of the financial year’s close. For FY25, the deadline has been extended till September 30, 2025.

The code caps free evaluation samples at 2% of domestic sales, with valuation to be recorded at stockist price if manufactured in-house, or at purchase price if sourced externally. Companies must also disclose spending on samples, CME programs, event sponsorships and pre approvals needed for specialist doctor international travels , lodging, and hospitality in a newly prescribed annexure format.

In a move aimed at eliminating conflicts of interest, the revised framework prohibits gifts, cash grants, and personal travel or hospitality benefits to healthcare professionals and their families. Industry associations will be required to retain disclosure data for five years, with stricter penalties for violations.

“At AiMeD we welcome the Universal Code of Ethical Marketing of Medical Devices and the simplified annual reporting format. The Code ensures ethical and transparent marketing, fostering fair competition and stronger reputations for both domestic and overseas manufacturers. Patients benefit through safer devices, trustworthy information, and freedom from exploitative promotions,” said Rajiv Nath, Forum Coordinator, AiMeD.

India’s medical device sector, valued at around $20 billion currently, is projected to grow to $50 billion by 2030 under the Atmanirbhar Bharat vision. AiMeD said that by mandating transparent disclosures and curbing inducements, the UCMPMD will help create a level playing field, reduce unfair practices, and enhance public trust in medical devices and the healthcare ecosystem.

The industry body urged companies to ensure timely compliance, noting that the reforms reward ethical players while strengthening patient-centric practices.